CC

Business Context and Reporting Period

The Chemours Company (CC) filed its Form 10-Q for the quarterly period ended June 30, 2025. Chemours is a global provider of performance chemicals operating through three principal segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. The company reported a significant net loss for the quarter and the first half of the year, primarily driven by substantial litigation and environmental charges related to PFAS matters.

Key Financial Metrics

Note: YTD Free Cash Flow calculated as Operating Cash Flow less Capital Expenditures ($127M).

Material Changes vs. Prior Period

• Profitability Decline: The company swung from a net income of $60 million in Q2 2024 to a net loss of $380 million in Q2 2025. This was primarily due to a $299 million litigation-related charge and a $60 million environmental charge recorded in the quarter.
• SG&A Expense Surge: Selling, general, and administrative expenses increased by 184% year-over-year (from $154M to $437M) due to the aforementioned litigation accruals.
• Revenue Growth: Net sales increased 4% in Q2 2025 and 2% YTD 2025, driven by volume growth in the Thermal & Specialized Solutions segment (Opteon refrigerants) and price increases in Advanced Performance Materials.
• Segment Performance:
  • Thermal & Specialized Solutions: Adjusted EBITDA increased 29% to $207M, driven by strong Opteon demand.
  • Titanium Technologies: Adjusted EBITDA decreased 43% to $47M due to price declines and operational disruptions (rail line interruptions).
  • Advanced Performance Materials: Adjusted EBITDA increased 11% to $50M, despite volume weakness, due to pricing and cost management.

Guidance, Outlook, and Risks

• Legal and Environmental Contingencies: The company recorded a $257 million accrual for its share of a settlement with the State of New Jersey regarding PFAS liabilities. Total accrued litigation liabilities stand at $497 million. Management notes that potential losses related to PFAS matters could be material and are not fully estimable.
• Operational Disruptions: In July 2025, a power outage at the Washington Works facility caused a full shutdown and equipment damage, expected to impact sales and incur additional costs in Q3 2025.
• Liquidity: The company maintains $502 million in unrestricted cash and $954 million in availability under its revolving credit facility. Management believes liquidity is sufficient to meet obligations through August 2026.
• Regulatory Risks: Ongoing EPA actions regarding PFAS drinking water standards and EU restrictions on PFAS substances pose significant risks to future operations and remediation costs.
• Tax Legislation: The "One Big Beautiful Bill Act" enacted in July 2025 may allow for the release of a portion of the valuation allowance recorded in Q2, potentially impacting future effective tax rates.

Investor Verification Checklist

• Settlement Terms: Verify the specific payment schedule and total undiscounted value of the New Jersey PFAS settlement ($875M total over 25 years; Chemours share $257M NPV).
• Remediation Estimates: Review the range of potential Remediation Funding Source (RFS) amounts for New Jersey sites ($177M to $1,048M) and the likelihood of additional accruals.
• Washington Works Impact: Assess the duration of the Q3 shutdown and the specific cost implications of the equipment damage.
• Valuation Allowance: Monitor the release of the $169 million valuation allowance against deferred tax assets in Q3 2025 as anticipated by management.
• Segment Margins: Track Titanium Technologies' ability to recover margins following operational disruptions and price declines.